14-day Premium Trial Subscription Try For FreeTry Free

Range Low Price High Price Comment
30 days $40.39 $44.07 Friday, 3rd May 2024 IONS stock ended at $41.97. This is 2.60% less than the trading day before Thursday, 2nd May 2024. During the day the stock fluctuated 4.36% from a day low at $41.93 to a day high of $43.76.
90 days $40.39 $51.98
52 weeks $34.79 $54.44

Historical Ionis Pharmaceuticals prices

Date Open High Low Close Volume
Nov 02, 2023 $46.04 $46.12 $43.43 $43.73 1 137 852
Nov 01, 2023 $44.56 $45.51 $44.17 $45.26 991 710
Oct 31, 2023 $43.83 $44.41 $43.40 $44.27 782 117
Oct 30, 2023 $43.98 $44.68 $43.95 $44.00 595 711
Oct 27, 2023 $45.67 $45.67 $43.95 $44.05 783 925
Oct 26, 2023 $44.59 $45.91 $44.01 $45.63 805 624
Oct 25, 2023 $45.85 $46.32 $44.23 $44.37 982 539
Oct 24, 2023 $45.93 $46.58 $45.88 $46.28 755 061
Oct 23, 2023 $46.68 $47.47 $45.78 $45.79 1 076 739
Oct 20, 2023 $46.42 $46.87 $46.02 $46.16 1 176 051
Oct 19, 2023 $46.12 $47.53 $45.62 $46.56 1 245 158
Oct 18, 2023 $48.31 $48.53 $45.89 $45.98 1 507 978
Oct 17, 2023 $47.97 $48.75 $47.92 $48.51 1 122 742
Oct 16, 2023 $47.74 $48.24 $47.32 $48.14 1 081 704
Oct 13, 2023 $46.30 $48.05 $45.95 $47.98 1 297 932
Oct 12, 2023 $46.80 $47.02 $45.85 $46.10 847 148
Oct 11, 2023 $46.99 $47.20 $45.89 $46.91 509 992
Oct 10, 2023 $46.34 $46.79 $46.05 $46.65 730 763
Oct 09, 2023 $46.20 $46.59 $45.83 $46.44 870 926
Oct 06, 2023 $46.70 $47.14 $46.25 $46.39 1 082 269
Oct 05, 2023 $43.45 $46.95 $43.45 $46.85 1 735 519
Oct 04, 2023 $43.37 $44.00 $43.07 $43.67 1 403 176
Oct 03, 2023 $43.39 $43.48 $41.88 $43.39 1 286 435
Oct 02, 2023 $45.23 $45.39 $43.05 $43.43 1 585 698
Sep 29, 2023 $47.00 $47.00 $45.22 $45.36 1 338 005
Click to get the best stock tips daily for free!

About Ionis Pharmaceuticals

Ionis Pharmaceuticals Ionis Pharmaceuticals, Inc. discovers and develops RNA-targeted therapeutics in the United States. The company offers SPINRAZA for spinal muscular atrophy (SMA) in pediatric and adult patients; TEGSEDI, an injection for the treatment of polyneuropathy of hereditary transthyretin-mediated amyloidosis in adults; and WAYLIVRA, a treatment for familial chylomicronemia syndrome and familial partial lipodystrophy. It also develops medicines for various... IONS Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT